BLOOD RESEARCH Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-0011   pISSN 2287-979X

 

Cited by CrossRef (5)

  1. Dominique Farge, Henri Bounameaux, Benjamin Brenner, Francis Cajfinger, Philippe Debourdeau, Alok A Khorana, Ingrid Pabinger, Susan Solymoss, James Douketis, Ajay Kakkar. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. The Lancet Oncology 2016;17:e452
    https://doi.org/10.1016/S1470-2045(16)30369-2
  2. Isabelle Mahé, Didier Mayeur, Ivan Krakowski. Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations. Support Care Cancer 2016;24:4105
    https://doi.org/10.1007/s00520-016-3224-0
  3. A. A. Fokin, K. V. Bagaev. Venous thromboembolic complications in oncological patients: present-day possibilities of effective and safe anticoagulant therapy. Angiol Sosud Khir 2019;25:19
    https://doi.org/10.33529/angio2019102
  4. Ho-Young Yhim, Won-Il Choi, Sung-Hyun Kim, Seung-Hyun Nam, Kyoung Ha Kim, Yeung-Chul Mun, Doyeun Oh, Hun-Gyu Hwang, Keun-Wook Lee, Eun-Kee Song, Yong Shik Kwon, Soo-Mee Bang. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial. Korean J Intern Med 2019;34:1125
    https://doi.org/10.3904/kjim.2018.097
  5. I. Elalamy, I. Mahé, W. Ageno, G. Meyer. Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulant. J Thromb Haemost 2017;15:848
    https://doi.org/10.1111/jth.13659